BIOLIFE SOLUTIONS INC

BIOLIFE SOLUTIONS INC (BLFS) is a US-listed equity tracked across major market indices. BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

The company reports net income of $1.19M. Key metrics include a return on equity of 0.3%, a debt-to-equity ratio of 0.08.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for BLFS to support both active traders and long-term investors.